1. Home
  2. BDL vs ECOR Comparison

BDL vs ECOR Comparison

Compare BDL & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

HOLD

Current Price

$33.62

Market Cap

53.2M

ML Signal

HOLD

Logo electroCore Inc.

ECOR

electroCore Inc.

HOLD

Current Price

$5.60

Market Cap

52.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDL
ECOR
Founded
1959
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
52.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BDL
ECOR
Price
$33.62
$5.60
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.00
AVG Volume (30 Days)
1.6K
72.4K
Earning Date
02-10-2026
03-11-2026
Dividend Yield
1.64%
N/A
EPS Growth
75.14
N/A
EPS
3.11
N/A
Revenue
$208,640,000.00
$29,835,000.00
Revenue This Year
N/A
$28.92
Revenue Next Year
N/A
$32.50
P/E Ratio
$10.81
N/A
Revenue Growth
8.12
27.90
52 Week Low
$22.61
$4.16
52 Week High
$35.98
$19.49

Technical Indicators

Market Signals
Indicator
BDL
ECOR
Relative Strength Index (RSI) 57.26 45.62
Support Level $32.25 $5.15
Resistance Level $33.21 $5.73
Average True Range (ATR) 0.82 0.55
MACD 0.10 -0.18
Stochastic Oscillator 100.00 17.49

Price Performance

Historical Comparison
BDL
ECOR

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: